{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:52:30Z","timestamp":1793242350921,"version":"4.5.0"},"reference-count":52,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"Importance<\/jats:title>Methadone treatment (MT) fails to address the emotion dysregulation, pain, and reward processing deficits that often drive opioid use disorder (OUD). New interventions are needed to address these factors.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate the efficacy of MT as usual (usual care) vs telehealth Mindfulness-Oriented Recovery Enhancement (MORE) plus usual care among people with an OUD and pain.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This study was a randomized clinical trial conducted from August 2020 to June 2022. Participants receiving MT for OUD and experiencing chronic pain were recruited at 5 clinics in New Jersey.<\/jats:p><\/jats:sec>Interventions<\/jats:title>In usual care, participants received MT, including medication and counseling. Participants receiving MORE plus usual care attended 8 weekly, 2-hour telehealth groups that provided training in mindfulness, reappraisal, and savoring in addition to usual care.<\/jats:p><\/jats:sec>Main Outcomes and Measure<\/jats:title>Primary outcomes were return to drug use and MT dropout over 16 weeks. Secondary outcomes were days of drug use, methadone adherence, pain, depression, and anxiety. Analyses were based on an intention-to-treat approach.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 154 participants (mean [SD] age, 48.5 [11.8] years; 88 female [57%]) were included in the study. Participants receiving MORE plus usual care had significantly less return to drug use (hazard ratio [HR],\u20090.58; 95% CI, 0.37-0.90; P<\/jats:italic>\u2009=\u2009.02) and MT dropout (HR,\u20090.41; 95% CI, 0.18-0.96; P<\/jats:italic>\u2009=\u2009.04) than those receiving usual care only after adjusting for a priori\u2013specified covariates (eg, methadone dose and recent drug use, at baseline). A total of 44 participants (57.1%) in usual care and 39 participants (50.6%) in MORE plus usual care returned to drug use. A total of 17 participants (22.1%) in usual care and 10 participants (13.0%) in MORE plus usual care dropped out of MT. In zero-inflated models, participants receiving MORE plus usual care had significantly fewer days of any drug use (ratio of means\u2009=\u20090.58; 95% CI, 0.53-0.63; P<\/jats:italic>\u2009&amp;lt;\u2009.001) than those receiving usual care only through 16 weeks. A significantly greater percentage of participants receiving MORE plus usual care maintained methadone adherence (64 of 67 [95.5%]) at the 16-week follow-up than those receiving usual care only (56 of 67 [83.6%]; \u03c72<\/jats:sup>\u2009=\u20094.49; P<\/jats:italic>\u2009=\u2009.04). MORE reduced depression scores and ecological momentary assessments of pain through the 16-week follow-up to a significantly greater extent than usual care (group \u00d7 time F<\/jats:italic>2,272<\/jats:sub>\u2009=\u20093.13; P<\/jats:italic>\u2009=\u2009.05 and group \u00d7 time F<\/jats:italic>16,13000<\/jats:sub>\u2009=\u20096.44; P<\/jats:italic>\u2009&amp;lt;\u2009.001, respectively). Within the MORE plus usual care group, EMA pain ratings decreased from a mean (SD) of 5.79 (0.29) at baseline to 5.17 (0.30) at week 16; for usual care only, pain decreased from 5.19 (0.28) at baseline to 4.96 (0.29) at week 16. Within the MORE plus usual care group, mean (SD) depression scores were 22.52 (1.32) at baseline and 18.98 (1.38) at 16 weeks. In the usual care\u2013only group, mean (SD) depression scores were 22.65 (1.25) at baseline and 20.03 (1.27) at 16 weeks. Although anxiety scores increased in the usual care\u2013only group and decreased in the MORE group, this difference between groups did not reach significance (group \u00d7 time unadjusted F<\/jats:italic>2,272<\/jats:sub>\u2009= 2.10; P<\/jats:italic>= .12; Cohen d<\/jats:italic> = .44; adjusted F<\/jats:italic>2,268<\/jats:sub> = 2.33; P <\/jats:italic>= .09). Within the MORE plus usual care group, mean (SD) anxiety scores were 25.5 (1.60) at baseline and 23.45 (1.73) at 16 weeks. In the usual care\u2013only group, mean (SD) anxiety scores were 23.27 (1.75) at baseline and 24.07 (1.73) at 16 weeks.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This randomized clinical trial demonstrated that telehealth MORE was a feasible adjunct to MT with significant effects on drug use, pain, depression, treatment retention, and adherence.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT04491968<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2023.5138","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T01:30:39Z","timestamp":1701999039000},"page":"338","source":"Crossref","is-referenced-by-count":47,"title":["Telehealth Mindfulness-Oriented Recovery Enhancement vs Usual Care in Individuals With Opioid Use Disorder and Pain"],"prefix":"10.1001","volume":"81","author":[{"given":"Nina A.","family":"Cooperman","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Division of Addiction Psychiatry, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-En","family":"Lu","sequence":"additional","affiliation":[{"name":"Rutgers School of Public Health, Piscataway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam W.","family":"Hanley","sequence":"additional","affiliation":[{"name":"College of Social Work, University of Utah, Salt Lake City"},{"name":"Center on Mindfulness and Integrative Health Intervention Development, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanusha","family":"Puvananayagam","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Division of Addiction Psychiatry, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Dooley-Budsock","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Division of Addiction Psychiatry, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kline","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Division of Addiction Psychiatry, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Garland","sequence":"additional","affiliation":[{"name":"College of Social Work, University of Utah, Salt Lake City"},{"name":"Center on Mindfulness and Integrative Health Intervention Development, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"22","key":"yoi230105r3","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014tackling the opioid-overdose epidemic.","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"yoi230105r4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/00952990802342899","article-title":"A meta-analysis of retention in methadone maintenance by dose and dosing strategy.","volume":"35","author":"Bao","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"key":"yoi230105r5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4137\/SART.S37030","article-title":"A prospective study to investigate predictors of relapse among patients with opioid use disorder treated with methadone.","volume":"10","author":"Naji","year":"2016","journal-title":"Subst Abuse"},{"issue":"1","key":"yoi230105r6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/vsu.v22.1","article-title":"Chronic and acute pain and pain management for patients in methadone maintenance treatment.","volume":"22","author":"Eyler","year":"2013","journal-title":"Am J Addict"},{"issue":"2","key":"yoi230105r7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/15504263.2016.1172896","article-title":"Influence of psychiatric and personality disorders on smoking cessation among individuals in opiate dependence treatment.","volume":"12","author":"Cooperman","year":"2016","journal-title":"J Dual Diagn"},{"issue":"1","key":"yoi230105r8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1360-0443.1998.931738.x","article-title":"A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction.","volume":"93","author":"Brewer","year":"1998","journal-title":"Addiction"},{"issue":"3","key":"yoi230105r9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/00952991003736389","article-title":"Predictors of attrition from a national sample of methadone maintenance patients.","volume":"36","author":"Mancino","year":"2010","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"yoi230105r10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.drugalcdep.2005.09.005","article-title":"Response to methadone maintenance treatment of opiate dependent patients with and without significant pain.","volume":"82","author":"Ilgen","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"yoi230105r11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0885-3924(99)00144-X","article-title":"Characteristics of methadone maintenance patients with chronic pain.","volume":"19","author":"Jamison","year":"2000","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"yoi230105r12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/npp.2013.289","article-title":"Abnormal brain activity during a reward and loss task in opiate-dependent patients receiving methadone maintenance therapy.","volume":"39","author":"Gradin","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 1","key":"yoi230105r13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuropharm.2008.07.035","article-title":"A somatic marker theory of addiction.","volume":"56","author":"Verdejo-Garc\u00eda","year":"2009","journal-title":"Neuropharmacology"},{"issue":"1","key":"yoi230105r14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction.","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"yoi230105r15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2015.11.027","article-title":"Common brain mechanisms of chronic pain and addiction.","volume":"89","author":"Elman","year":"2016","journal-title":"Neuron"},{"issue":"4","key":"yoi230105r16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s11606-009-0908-x","article-title":"Providers\u2019 experiences treating chronic pain among opioid-dependent drug users.","volume":"24","author":"Berg","year":"2009","journal-title":"J Gen Intern Med"},{"issue":"2","key":"yoi230105r17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/ADM.0b013e31815ec240","article-title":"Counselors\u2019 experiences treating methadone-maintained patients with chronic pain: a needs assessment study.","volume":"2","author":"Barry","year":"2008","journal-title":"J Addict Med"},{"issue":"10","key":"yoi230105r18","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.4088\/JCP.15m09963","article-title":"Psychiatric disorders among patients seeking treatment for co-occurring chronic pain and opioid use disorder.","volume":"77","author":"Barry","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"yoi230105r19","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1093\/pm\/pnw327","article-title":"Drug Counselor Responses to patients\u2019 pain reports: a qualitative investigation of barriers and facilitators to treating patients with chronic pain in methadone maintenance treatment.","volume":"18","author":"Beitel","year":"2017","journal-title":"Pain Med"},{"issue":"1","key":"yoi230105r20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/nyas.2016.1373.issue-1","article-title":"Restructuring reward processing with mindfulness-oriented recovery enhancement: novel therapeutic mechanisms to remediate hedonic dysregulation in addiction, stress, and pain.","volume":"1373","author":"Garland","year":"2016","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"yoi230105r21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax1569","article-title":"Mindfulness-oriented recovery enhancement remediates hedonic dysregulation in opioid users: neural and affective evidence of target engagement.","volume":"5","author":"Garland","year":"2019","journal-title":"Sci Adv"},{"issue":"3","key":"yoi230105r22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1037\/a0035798","article-title":"Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.","volume":"82","author":"Garland","year":"2014","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"yoi230105r23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1037\/amp0000638","article-title":"Mindfulness-oriented recovery enhancement reduces opioid dose in primary care by strengthening autonomic regulation during meditation.","volume":"75","author":"Garland","year":"2020","journal-title":"Am Psychol"},{"issue":"10","key":"yoi230105r24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1037\/ccp0000390","article-title":"Mindfulness-oriented recovery enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: a randomized controlled trial.","volume":"87","author":"Garland","year":"2019","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"yoi230105r25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1037\/a0035798","article-title":"Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.","volume":"82","author":"Garland","year":"2014","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"yoi230105r26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamainternmed.2022.0033","article-title":"Mindfulness-oriented recovery enhancement vs supportive group therapy for co-occurring opioid misuse and chronic pain in primary care: a randomized clinical trial.","volume":"182","author":"Garland","year":"2022","journal-title":"JAMA Intern Med"},{"key":"yoi230105r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108468","article-title":"Pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: impact on illicit drug use, health, and well-being.","volume":"127","author":"Cooperman","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"yoi230105r28","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"yoi230105r30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/26408066.2020.1833803","article-title":"The mindfulness-oriented recovery enhancement fidelity measure (MORE-FM): development and validation of a new tool to assess therapist adherence and competence.","volume":"18","author":"Hanley","year":"2021","journal-title":"J Evid Based Soc Work (2019)"},{"issue":"3","key":"yoi230105r31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the Addiction Severity Index.","volume":"9","author":"McLellan","year":"1992","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"yoi230105r32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"issue":"3","key":"yoi230105r34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale: A self-report depression scale for research in the general population.","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl Psychol Meas"},{"issue":"6","key":"yoi230105r35","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties.","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"issue":"5","key":"yoi230105r36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jamapsychiatry.2013.4546","article-title":"Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.","volume":"71","author":"Bowen","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi230105r37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/1269547","article-title":"Zero-inflated Poisson regression, with an application to defects in manufacturing.","volume":"34","author":"Lambert","year":"1992","journal-title":"Technometrics"},{"issue":"3","key":"yoi230105r38","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","article-title":"Inference and missing data.","volume":"63","author":"Rubin","year":"1976","journal-title":"Biometrika"},{"issue":"9988","key":"yoi230105r39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0140-6736(14)62222-4","article-title":"Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.","volume":"386","author":"Kuyken","year":"2015","journal-title":"Lancet"},{"issue":"16","key":"yoi230105r40","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1007\/s00213-014-3504-7","article-title":"Effects of mindfulness-oriented recovery enhancement on reward responsiveness and opioid cue-reactivity.","volume":"231","author":"Garland","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"yoi230105r41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10865-014-9607-0","article-title":"Neurophysiological evidence for remediation of reward processing deficits in chronic pain and opioid misuse following treatment with mindfulness-oriented recovery enhancement: exploratory ERP findings from a pilot RCT.","volume":"38","author":"Garland","year":"2015","journal-title":"J Behav Med"},{"issue":"41","key":"yoi230105r42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo4455","article-title":"Mindfulness-induced endogenous theta stimulation occasions self-transcendence and inhibits addictive behavior.","volume":"8","author":"Garland","year":"2022","journal-title":"Sci Adv"},{"key":"yoi230105r43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2021.110585","article-title":"Mindfulness-based interventions for medication adherence: a systematic review and narrative synthesis.","volume":"149","author":"Nardi","year":"2021","journal-title":"J Psychosom Res"},{"issue":"2","key":"yoi230105r44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"issue":"5","key":"yoi230105r45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3109\/10826084.2014.991405","article-title":"Determining smoking cessation related information, motivation, and behavioral skills among opiate dependent smokers in methadone treatment.","volume":"50","author":"Cooperman","year":"2015","journal-title":"Subst Use Misuse"},{"issue":"3","key":"yoi230105r46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.31887\/DCNS.2017.19.3\/tcicero","article-title":"The prescription opioid epidemic: a review of qualitative studies on the progression from initial use to abuse.","volume":"19","author":"Cicero","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"issue":"5","key":"yoi230105r48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The self-medication hypothesis of substance use disorders: a reconsideration and recent applications.","volume":"4","author":"Khantzian","year":"1997","journal-title":"Harv Rev Psychiatry"},{"issue":"1","key":"yoi230105r49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1037\/0033-295X.111.1.33","article-title":"Addiction motivation reformulated: an affective processing model of negative reinforcement.","volume":"111","author":"Baker","year":"2004","journal-title":"Psychol Rev"},{"issue":"4","key":"yoi230105r50","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/02791072.2007.10399889","article-title":"Negative affect, emotional acceptance, and smoking cessation.","volume":"39","author":"Carmody","year":"2007","journal-title":"J Psychoactive Drugs"},{"issue":"1","key":"yoi230105r51","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1037\/bul0000003","article-title":"Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.","volume":"141","author":"Leventhal","year":"2015","journal-title":"Psychol Bull"},{"key":"yoi230105r52","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s40429-023-00492-5","article-title":"The use of ecological momentary assessment methods with people receiving medication for opioid use disorder: a systematic review.","volume":"10","author":"Alexander","year":"2023","journal-title":"Curr Addict Rep"},{"key":"yoi230105r29","volume-title":"Mindfulness-Oriented Recovery Enhancement for Addiction, Stress, and Pain","author":"Garland","year":"2013"},{"key":"yoi230105r33","volume-title":"Brief Pain Inventory\u2013Short Form","author":"Cleeland","year":"1994"},{"key":"yoi230105r47","volume-title":"Coping and Substance Use","author":"Wills","year":"1985"},{"key":"yoi230105r1","unstructured":"American Society of Addiction Medicine. Opioid addiction 2016 facts & figures. 2017. Accessed July 9, 2023. https:\/\/www.asam.org\/docs\/default-source\/advocacy\/opioid-addiction-disease-facts-figures.pdf"},{"key":"yoi230105r2","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Biden administration announces $1.5 billion funding opportunity for state opioid response grant program. 2022. Accessed July 9, 2023. https:\/\/www.samhsa.gov\/newsroom\/press-announcements\/20220519\/biden-administration-announces-1-point-5-billion-funding-state-opioid-response"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2812818\/jamapsychiatry_cooperman_2023_oi_230105_1711140315.81266.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T15:27:08Z","timestamp":1712158028000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2812818"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.5138","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,1]]}}}